Karen Kingston is a biotech analyst and former Pfizer employee who understands complicated medical and biological contracts. Kingston has been doing a deep dive into the contract President Trump signed with Pfizer for their version of the CV19 vax. The contract proves Trump required Pfizer to follow the law to produce a safe and effective vaccine. The Pfizer vax was not safe or effective and violated the contract. On top of that, the Pfizer vax turned out to be a bioweapon. Pfizer says it produced 63% of the 13 billion injections worldwide. Kingston explains, “Unlike any other contract I have ever read before, the contract says right up front the President said they had to produce a safe and effective vaccine, and they would have to promise it would protect against SARS-Cov-2 infections and all its variants. Oh, and by the way, all those Emergency Use Authorization (EUA) laws that give you immunity under Obama and Bush, Jr., you are going to forfeit those. . . . Trump said he wanted it by October 31, and the vaccine must be safe and effective. This was not safe and effective under the emergency use vaccine even though it was going to be EUA authorized. They cite the FDA laws under initial new drug applications that it must adhere to. In fact, Pfizer had to adhere to initial new drug application laws that were separate from EUA laws. On top of that, it had to be guaranteed to be safe and effective. . . . The contract that Trump had Pfizer sign made them guarantee this was safe and effective. So, they broke the contract, and Pfizer is not protected under the EUA law. . . . The way the contract is written, it looks to me, Trump said if we need a vaccine to reopen the country, you have to make sure it was safe and effective. . . . The phrase is in there over a dozen times. There is no gray area that the product (Pfizer CV19 vax) had to be safe and effective.”
